PC

Pullan Consulting at BIO-Europe 2026

Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website

Pullan Consulting takes part in 1 session at BIO-Europe 2026 in Cologne. Its program centres on cancer drug investment, asking where investors, pharma and biotech are placing their bets on the next oncology winners. The discussion is shared with Debiopharm, Epitopea and Women in Life Science Denmark.

OrganizationBIO-Europe 2026 Attendance
PC
Pullan Consulting
Panel
Mon Nov 9
15:00–15:45
The next oncology winners: Where investors, pharma and biotech are placing their bets
Which cancer treatments, from radioactive targeted drugs to newer immunotherapies, now draw investors, and what makes a cancer biotech worth funding.
with Debiopharm, Women in Life Science Denmark, Epitopea

Explore the full BIO-Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Cologne. Leave your work email and we’ll be in touch.

Privacy

Download the full BIO-Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Pullan Consulting

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EBD Group, Informa Connect or BIO-Europe. Submit a correction